Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $64,168 | $60,115 | $59,283 | $48,704 |
| % Growth | 6.7% | 1.4% | 21.7% | – |
| Cost of Goods Sold | $15,193 | $16,126 | $17,411 | $13,626 |
| Gross Profit | $48,975 | $43,989 | $41,872 | $35,078 |
| % Margin | 76.3% | 73.2% | 70.6% | 72% |
| R&D Expenses | $17,938 | $30,531 | $13,548 | $12,245 |
| G&A Expenses | $7,700 | $7,584 | $7,469 | $7,403 |
| SG&A Expenses | $10,100 | $9,884 | $9,669 | $9,403 |
| Sales & Mktg Exp. | $2,400 | $2,300 | $2,200 | $2,000 |
| Other Operating Expenses | $716 | $620 | $373 | $231 |
| Operating Expenses | $28,754 | $41,035 | $23,590 | $21,879 |
| Operating Income | $20,221 | $2,954 | $18,282 | $13,199 |
| % Margin | 31.5% | 4.9% | 30.8% | 27.1% |
| Other Income/Exp. Net | -$285 | -$1,065 | -$1,838 | $680 |
| Pre-Tax Income | $19,936 | $1,889 | $16,444 | $13,879 |
| Tax Expense | $2,803 | $1,512 | $1,918 | $1,521 |
| Net Income | $17,117 | $365 | $14,519 | $13,049 |
| % Margin | 26.7% | 0.6% | 24.5% | 26.8% |
| EPS | 6.76 | 0.14 | 5.73 | 5.16 |
| % Growth | 4,728.6% | -97.6% | 11% | – |
| EPS Diluted | 6.74 | 0.14 | 5.71 | 5.14 |
| Weighted Avg Shares Out | 2,532 | 2,607 | 2,532 | 2,530 |
| Weighted Avg Shares Out Dil | 2,541 | 2,547 | 2,542 | 2,538 |
| Supplemental Information | – | – | – | – |
| Interest Income | $415 | $365 | $157 | $36 |
| Interest Expense | $1,271 | $1,146 | $962 | $806 |
| Depreciation & Amortization | $4,499 | $3,872 | $3,909 | $3,214 |
| EBITDA | $25,706 | $6,907 | $21,315 | $17,899 |
| % Margin | 40.1% | 11.5% | 36% | 36.8% |